Azelis Group N.V. (0AA6)
London Stock Exchange · UK · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 11.65 |
|---|---|
| 52-week range | 6.86 – 13.54 |
| Return, 1 month / 3 months | −3.2% / +9.6% |
| Return, 1 year / 3 years | +8.6% / −25.0% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 39 |
| Volatility (1 year) | 36.6% |
| Worst drawdown (1 year) | -32.6% |
| Average daily value traded | 0.77M EUR |
| Dividend yield | 1.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Azelis Group is a distributor of specialty chemicals and ingredients based in Belgium. The company supplies a broad range of ingredients and chemical products to manufacturers in sectors such as food and beverage, personal care, home care, pharmaceuticals, agriculture and industrial coatings. It serves customers through local operating companies spread across Europe, the Americas, Asia-Pacific and Africa, combining product distribution with technical and formulation support for its supplier and customer partners.
The shares are listed on the London Stock Exchange in UK under the code 0AA6, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Azelis Group N.V. (0AA6) trades on the London Stock Exchange in UK. It last closed at EUR 11.65 on 27 October 2026.
Its price-based Market X-Ray is 58 out of 100 (a fair price profile), ranking 1,474 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 8.6% and over the last three months it rose 9.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 78 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 14.1% | ||
| From 52-week high | -13.1% | ||
| Momentum | 67 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 9.6% | ||
| 6-month return | 6.3% | ||
| 12-month return, skipping the last month | 12.3% | ||
| Stability (higher is calmer) | 45 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 36.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.6% | ||
| Liquidity | 50 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.77M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 32 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.4% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −10.5% |
|---|---|
| 1 month | −3.2% |
| 3 months | +9.6% |
| 6 months | +6.3% |
| 1 year | +8.6% |
| 3 years | −25.0% |
| 5 years | −56.5% |
Signals
| 50-day / 200-day average | 12.17 / 10.21 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.36 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Jun 2026 | EUR 0.1582 |
| 27 Jun 2025 | EUR 0.1578 |
| 28 Jun 2024 | EUR 0.1540 |
| 21 Jun 2023 | EUR 0.1947 |
| 20 Jun 2022 | EUR 0.0210 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.